Ninjurin-1 Antibody (758926) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB51051C
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Immunohistochemistry
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 758926
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human Ninjurin-1
Asp2-Val81
Accession # Q92982
Asp2-Val81
Accession # Q92982
Specificity
Detects human Ninjurin-1 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant
human Ninjurin-2 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Ninjurin-1 Antibody (758926) [PerCP]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Ninjurin-1
Alternate Names
NIN1, NINJ1, Ninjurin1
Gene Symbol
NINJ1
Additional Ninjurin-1 Products
Product Documents for Ninjurin-1 Antibody (758926) [PerCP]
Product Specific Notices for Ninjurin-1 Antibody (758926) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...